2023 Apr 28 Head and Neck Surgical Oncology Grand Rounds
Updates in Otology Grand Rounds
Speaker(s):
Ghedak Ansari, MD,
Kaiser Permanente, Oakland
Caitlin Pacheco, MD
Kaiser Permanente, Oakland
Peter Debbaneh, MD
Kaiser Permanente, Oakland
Nik Block, MD
Kaiser Permanente, Oakland
Jacob Hoerter, MD
Kaiser Permanente, Oakland
Elias Saba, MD
Kaiser Permanente, Oakland
Seo Moon, MD
Kaiser Permanente, Oakland
Kevin Wang, MD
Kaiser Permanente, Oakland
Statement of Disclosure:
Kaiser Foundation Hospital Oakland/Richmond has determined that none of the speakers, planning committee members, and consultants for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Kaiser Foundation Hospital Oakland/Richmond does not endorse any brand name products.
Kaiser Foundation Hospital Oakland/Richmond is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
Kaiser Foundation Hospital Oakland/Richmond designates this live activity for a maximum of 2.0 AMA PRA Category 1 credit(s)TM.. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses may report up to a maximum of 1.0 hours of credit towards the continuing medical education requirements for license renewal by the California Board of Registered Nurses.
Target Audience
This program will be of interest to all primary care physicians. Specialist and other interested clinicians are invited to attend within their scope of practice where applicable.
Learning Objectives
As a result of this education, participants will be able to:
- Describe the unique laboratory work-up of patients with medullary thyroid cancer, as well as identify relevant genetic profiles associated with the disease.
- Understand updates in immunotherapy used for advanced cutaneous squamous cell carcinoma and be able to counsel patients on their use.
- Describe the unique association between nasopharyngeal carcinoma and EBV, as well as stratify patient risk based on lab values.
Additional Information
Available Credit
- 2.00 AMA PRA Category 1 Credit(s)™
- 4.00 Attendance